Research Article
The Impact of 18F-FDG PET CT Prior to Chemoradiotherapy for Stage III/IV Head and Neck Squamous Cell Carcinoma
Table 1
Disease site, subsite, stage, histology, and intended treatment prior to PET-CT examination.
| Characteristic | Number (%) |
| Oropharynx Tonsil Base of tongue Posterior pharyngeal wall | 47 (85%) 25 21 1 | Hypopharynx Pyriform fossa | 4 (7%) 4 | Larynx Supraglottis | 2 (4%) 2 | Paranasal sinus | 1 (2%) | Oral cavity Retromolar trigone | 1 (2%) 1 | Stage | | III IV | 14 (25%) 41 (75%) | Histology | | SCC Poorly differentiated Moderately differentiated Well differentiated Not classified | 55 (100%) 29 (53%) 18 (33%) 0 (0%) 8 (15%) | Intended treatment | | Radical radiotherapy | 12 (22%) | Concurrent chemoradiotherapy | 36 (65%) | Induction + concurrent chemoradiotherapy | 6 (11%) | Concurrent cetuximab and radiotherapy | 1 (2%) |
|
|